Related Experiment Video
Updated: Jul 14, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy
Tomoki Kosugi1, Yukio Yuzawa, Waichi Sato
1Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Abstract:
The concept that inflammation plays a crucial role in the pathogenesis of diabetic nephropathy has been recently emerging, although the principal pathology of diabetic nephropathy comprises glomerular sclerosis and associated changes in nephrons. Here, we identified the growth factor midkine (MK) as a novel key molecule involved in inflammation associated with Streptozotocin-induced diabetic nephropathy. The tubulointerstitial damage, as assessed as morphological changes, osteopontin expression, collagen I deposition and macrophage infiltration, were strikingly less in MK-deficient (Mdk(-/-)) mice than in Mdk(+/+) mice. Monocyte chemoattractant protein (MCP)-1 expression, but not that of intercellular adhesion molecule-1, was also lower in Mdk(-/-) mice. High glucose upregulated MK expression in primary-cultured tubular epithelial cells, and induced MCP-1 to a larger extent in Mdk(+/+) cells than in Mdk(-/-) cells. Correspondingly, the combination of exogenous MK and high glucose enhanced MCP-1 expression in Mdk(-/-) cells. Furthermore, high glucose and oxidant stress enhanced MK expression in macrophages. Consistent with the findings in the mouse model, MK expression was detected in the glomeruli, tubular epithelium and interstitium of kidneys from patients with diabetic nephropathy. Our data indicate that MK plays a critical role in the tubulointerstitial inflammation associated with diabetic nephropathy through activation of the MCP-1 pathway.
Insights
Midkine (MK) is a key molecule in diabetic kidney inflammation. MK deficiency reduces tubulointerstitial damage and monocyte chemoattractant protein-1 (MCP-1) levels in diabetic nephropathy models.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Diabetic nephropathy (DN) pathogenesis involves inflammation, though glomerular sclerosis is the primary pathology.
- Midkine (MK), a growth factor, is investigated for its role in DN-associated inflammation.
Purpose of the Study:
- To identify novel molecular players in inflammation during diabetic nephropathy.
- To investigate the role of midkine (MK) in Streptozotocin-induced diabetic nephropathy.
Main Methods:
- Utilized MK-deficient (Mdk(-/-)) and wild-type (Mdk(+/+)) mice in a Streptozotocin-induced diabetic nephropathy model.
- Assessed tubulointerstitial damage, macrophage infiltration, and expression of MK, monocyte chemoattractant protein-1 (MCP-1), and intercellular adhesion molecule-1 (ICAM-1).
- Examined MK and MCP-1 expression in high glucose-treated tubular epithelial cells and macrophages.
Main Results:
- MK deficiency significantly reduced tubulointerstitial damage, osteopontin expression, collagen I deposition, and macrophage infiltration in diabetic mice.
- Monocyte chemoattractant protein-1 (MCP-1) expression was lower in MK-deficient mice, while ICAM-1 was not significantly affected.
- High glucose upregulated MK in tubular cells and enhanced MCP-1 production, an effect amplified by exogenous MK.
- High glucose and oxidant stress increased MK expression in macrophages.
- MK was detected in kidneys of patients with diabetic nephropathy.
Conclusions:
- Midkine (MK) is a critical mediator of tubulointerstitial inflammation in diabetic nephropathy.
- MK activates the monocyte chemoattractant protein-1 (MCP-1) pathway, contributing to inflammation in diabetic kidney disease.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Nephrons
Diabetic Retinopathy